• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

American Society of Clinical Oncology (ASCO) - Articles and news items

Aprea announces efficacy and safety data for APR-246 in ovarian cancer

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Aprea presented clinical data from the Phase Ib part of the ongoing PiSARRO Phase Ib/II trial of APR-246 at the ASCO annual meeting…

Novartis presents new data for Tafinlar + Mekinist at ASCO

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Novartis has announced new data for the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in non-small cell lung cancer (NSCLC) and melanoma…

Positive Phase I data for IMCgp100 in metastatic melanoma

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Immunocore has announced positive data from the first in human, Phase I clinical trial of its lead ImmTAC, IMCgp100…

Merck releases new data for Keytruda at ASCO

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Keytruda is a humanised monoclonal antibody that works by increasing the ability of the body’s immune system to help detect and fight tumour cells…

IMAB362 extends survival in gastric cancer

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Ganymed announced data from its randomised Phase II clinical study of IMAB362 in first-line treatment of gastric cancer at the ASCO 2016 Annual Meeting…

Data for Alimta and Cyramza plus keytruda in NSCLC presented at ASCO

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Data were presented from two early-phase trials evaluating Lilly’s Alimta and Cyramza in combination with Merck’s Keytruda in patients with NSCLC…

BMS presents new data for Opdivo at ASCO

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

New data for Bristol-Myers Squibb’s Opdivo has been presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)…

Daratumumab extends PFS in patients with multiple myeloma

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Daratumumab, in combination with bortezomib and dexamethasone, demonstrated a 61% reduction in the risk of disease progression or death…

Boehringer Ingelheim at ASCO: Oncology and Innovation

Blog, Z Homepage promo / 6 June 2016 / Victoria White, Digital Content Producer

We recently caught up with Dr Jörg Barth, Boehringer Ingelheim, to find out more about the company’s oncology pipeline and presence at ASCO….

Trabectedin shown to improve disease control in patients with advanced soft tissue sarcoma

Industry news / 3 June 2015 / Victoria White

Janssen Research & Development has announced data from a Phase 3 study of trabectedin (YONDELIS) in patients with two common types of soft tissue sarcoma…

AbbVie presents Phase 2 results from study of veliparib in patients with NSCLC who are current smokers

Industry news / 3 June 2015 / Victoria White

AbbVie has announced findings from a Phase 2 study of a veliparib regimen in patients with non-small cell lung cancer (NSCLC) who are current smokers…

Cabazitaxel – carboplatin combination chemotherapy holds promise as treatment for advanced prostate cancer

Industry news / 1 June 2015 / Victoria White

A new study compared the effectiveness of cabazitaxel alone versus cabazitaxel combined with carboplatin in patients with mCRPC…

  • Page 1 of 2
  • 1
  • 2
  • >

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +